TLR9 and TLR7 agonists mediate distinct type I IFN responses in humans and nonhuman primates in vitro and in vivo
- 4 November 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 91 (1) , 147-158
Abstract
Human I-IFNs include IFN-β and 13 independently regulated subtypes of IFN-α (I-IFNs). TLR7 and -9 induce I-IFNs, but it is unknown whether their subtype repertoire is similar. This study used new PCR arrays that selectively amplify individual I-IFN subtype genes of human and nonhuman primates to characterize the TLR7- and -9-mediated IFN response in vitro and in vivo. We show that in human PBMCs, TLR7 agonists induce a rapid burst of I-IFN transcripts, consisting primarily of IFN-α1/13, -α2, and -α14. In contrast, TLR9 agonists, regardless of the type used (CpG C-, B-, or D-ODN), prompted slower but sustained expression of IFN-α1/13, -α2, -α7, -α8, -α10, -α14, -α16, and -α21. These qualitative differences were translated downstream as differences in the pattern of IFN-inducible genes. In macaque PBMCs, imiquimod produced a short burst of IFN mRNA, dominated by IFN-α8, whereas C- or D-ODN induced a greater than tenfold increase in transcripts for all I-IFN subtypes by 12 h of culture. Differences were more evident in vivo, where TLR7 and -9 agonists induced significantly different levels of I-IFN transcripts in skin. Although the rates of gene transcription differed significantly for individual TLR9 agonists, their IFN-α subtype signature was almost identical, indicating that the type of receptor dictates the quality of the I-IFN response in vitro and in vivo. These results may underlie the differential therapeutic effects of TLR7 and -9 agonists and should inform future clinical studies.Keywords
This publication has 58 references indexed in Scilit:
- Negative regulation of signaling by a soluble form of toll‐like receptor 9European Journal of Immunology, 2011
- A diverse range of gene products are effectors of the type I interferon antiviral responseNature, 2011
- A cell biological view of Toll-like receptor function: regulation through compartmentalizationNature Reviews Immunology, 2009
- TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNAImmunology & Cell Biology, 2008
- Evolution of the interferon alpha gene family in eutherian mammalsGene, 2007
- Ligand-induced conformational changes allosterically activate Toll-like receptor 9Nature Immunology, 2007
- Cytoplasmic Targeting Motifs Control Localization of Toll-like Receptor 9Journal of Biological Chemistry, 2006
- Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activationJournal of Experimental Medicine, 2006
- Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon inductionNature, 2005
- TLR9 signals after translocating from the ER to CpG DNA in the lysosomeNature Immunology, 2004